查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830918

2025年全球无管胰岛素帮浦市场报告

Tubeless Insulin Pump Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，无管胰岛素帮浦市场规模快速扩张，从2024年的18.4亿美元成长到2025年的22亿美元，复合年增长率达19.5%。预测期内的增长可归因于糖尿病盛行率的上升、对便捷、隐藏的胰岛素给药方式的需求不断增长、糖尿病管理意识的增强、报销政策的加强、患者对无痛胰岛素给药的偏好以及家庭医疗保健解决方案的扩展。

无管胰岛素帮浦市场规模预计将在未来几年快速成长，到2029年将达到44.4亿美元，复合年增长率为19.1%。预测期内的增长可归因于对谨慎易用的胰岛素输送系统的需求不断增长、对个性化糖尿病管理的日益重视、先进胰岛素设备的报销政策的扩大以及透过数位健康倡议不断提高的认知度。预测期内的主要趋势包括人工智慧血糖监测的整合、与智慧型手机应用程式的连接性增强、贴片设备的小型化、闭合迴路系统的采用以及可穿戴健康技术的广泛应用。

无管胰岛素帮浦是专为糖尿病患者设计的可穿戴医疗设备，无需外部导管即可持续输送胰岛素。它直接佩戴在皮肤上，并透过手持控制器进行无线通讯，为胰岛素给药提供了一种更便捷、更隐密的方法。

无管胰岛素帮浦主要分为穿戴式和植入式。穿戴式帮浦是一种佩戴在身上的紧凑型装置，可连续皮下输送短效胰岛素，最大限度地减少每日多次注射的需求。这类帮浦采用持续血糖监测 (CGM)、整合帮浦系统和标准无管胰岛素帮浦等技术，供医院、药局和电商平台等终端用户使用。

美国关税的快速上涨以及持续至2025年春季的贸易摩擦，对医疗设备产业产生了重大影响，尤其对进口诊断影像设备零件、手术用不銹钢和塑胶耗材的影响。医院和诊所抵制涨价，挤压了製造商的净利率。监管障碍加剧了这个问题，因为与关税相关的供应商变更通常需要设备重新认证，从而延缓了产品上市时间。企业正在透过双重采购关键零件、扩大国内商品化生产以及加快高性价比材料的研发来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供无管胰岛素帮浦市场统计数据，例如全球市场规模、各地区市场份额、竞争对手的市场份额、详细的无管胰岛素帮浦细分市场、市场趋势以及无管胰岛素帮浦行业的商机，为您提供在无管胰岛素帮浦行业取得成功所需的数据。本无管胰岛素帮浦市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

糖尿病盛行率的上升预计将在未来几年推动无管胰岛素帮浦市场的成长。糖尿病是一种慢性疾病，其特征是高血糖，因为身体无法产生或有效利用胰岛素。糖尿病患者的增加在很大程度上与肥胖率的上升有关，而肥胖率的上升与不良饮食和缺乏运动密切相关。无管胰岛素帮浦透过提供持续剂量的胰岛素并有效调节血糖值（无需每天多次注射）来帮助控製糖尿病。例如，美国公共卫生研究机构健康指标与评估研究所在 2023 年 6 月报告称，全球有超过 5 亿人患有糖尿病。预计到 2050 年，这一数字将增加一倍以上，达到 13 亿。因此，糖尿病盛行率的上升刺激了对无管胰岛素帮浦的需求。

无管胰岛素帮浦市场的新兴市场正专注于开发先进的解决方案，例如基础胰岛素舱，为仅需要背景胰岛素的 2 型糖尿病患者提供便利且经济高效的胰岛素输送。基础胰岛素舱是可穿戴泵，可输送持续的背景胰岛素以帮助控制血糖值，主要针对第 2 型糖尿病患者。 2023 年 4 月，美国医疗设备公司 Insulet Corporation 推出了 Omnipod GO，这是一款胰岛素输送装置，核准用于通常每天接受长效胰岛素注射的成年 2 型糖尿病患者。 Omnipod GO 是一种可穿戴的独立设备，可在 72 小时内输送一致、快速起效的胰岛素剂量。无管防水舱预先设定了 7 个每日剂量，范围从 10 到 40 个单位，无需移动设备即可使用。

2023年1月，总部位于美国的胰岛素输送和糖尿病技术公司Tandem Diabetes Care收购了AMF Medical SA，收购金额未揭露。此次收购透过Sigi帮浦的可充电设计减少电池浪费，同时扩展了Tandem先进的胰岛素输送解决方案组合，从而支持了Tandem的永续性倡议。总部位于瑞士的AMF Medical SA专注于生产可重复使用的贴片（无管）胰岛素帮浦。

无管胰岛素帮浦市场涵盖输液器、插入装置、黏贴式胶囊以及手持式或智慧型手机控制器的销售。该市场的价值指的是“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场的商品价值还包括商品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球无管胰岛素帮浦：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球无管胰岛素帮浦市场：成长率分析
  • 全球无管胰岛素帮浦市场表现：规模与成长，2019-2024
  • 全球无管胰岛素帮浦市场预测：规模与成长，2024-2029年，2034年
  • 全球无管胰岛素帮浦：总目标市场（TAM）

第六章 市场细分

  • 全球无管胰岛素帮浦市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 穿戴式胰岛素泵
  • 植入式胰岛素泵
  • 全球无管胰岛素帮浦市场：按技术、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 持续血糖监测（CGM）整合泵
  • 标准无内胎泵
  • 全球无管胰岛素帮浦市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 药局
  • 电子商务
  • 其他最终用户
  • 全球无管胰岛素帮浦市场：穿戴式胰岛素帮浦细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 贴片帮浦
  • 遥控泵浦
  • 支援蓝牙的泵
  • 一次性泵浦
  • 可重复使用泵浦
  • 全球无管胰岛素帮浦市场：依植入式胰岛素帮浦类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 可程式设计植入式泵
  • 可再填充植入式泵
  • 基于电子机械系统（MEMS）的泵
  • 长效植入帮浦
  • 生物相容性涂层泵

第七章 区域和国家分析

  • 全球无管胰岛素帮浦市场：区域分析、预测及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球无管胰岛素帮浦市场：依国家/地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 无管胰岛素帮浦市场：竞争格局
  • 无管胰岛素帮浦市场：公司简介
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Becton Dickinson & Company
  • Fresenius Kabi AG
  • Terumo Corporation
  • Insulet Corporation
  • Tandem Diabetes Care Inc.
  • Ypsomed AG
  • Ascensia Diabetes Care
  • MicroTech Medical
  • Menarini Diagnostics
  • Bigfoot Biomedical
  • Debiotech SA
  • Medtrum Technologies Inc.
  • Diabeloop
  • SOOIL Development
  • Beta Bionics

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年无管胰岛素帮浦市场：提供新机会的国家
  • 2029年无管胰岛素帮浦市场：细分市场带来新机会
  • 2029年无管胰岛素帮浦市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37911

A tubeless insulin pump is a wearable medical device designed for people with diabetes to provide continuous insulin delivery without the use of external tubing. It adheres directly to the skin and communicates wirelessly with a handheld controller, offering a more convenient and discreet method of insulin administration.

The primary types of tubeless insulin pumps include wearable and implantable insulin pumps. Wearable pumps are compact devices worn on the body that administer continuous doses of short-acting insulin subcutaneously, minimizing the need for multiple daily injections. These pumps utilize technologies such as continuous glucose monitoring (CGM), integrated pump systems, and standard tubeless pumps, and are utilized by end users including hospitals, pharmacies, e-commerce platforms, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The tubeless insulin pump market research report is one of a series of new reports from The Business Research Company that provides tubeless insulin pump market statistics, including the tubeless insulin pump industry global market size, regional shares, competitors with the tubeless insulin pump market share, detailed tubeless insulin pump market segments, market trends, and opportunities, and any further data you may need to thrive in the tubeless insulin pump industry. This tubeless insulin pump market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tubeless insulin pump market size has grown rapidly in recent years. It will grow from $1.84 billion in 2024 to $2.20 billion in 2025 at a compound annual growth rate (CAGR) of 19.5%. The growth in the historic period can be credited to the increasing prevalence of diabetes, rising demand for convenient and discreet insulin delivery methods, growing awareness about diabetes management, enhanced reimbursement policies, patient preference for pain-free insulin administration, and the expansion of home healthcare solutions.

The tubeless insulin pump market size is expected to see rapid growth in the next few years. It will grow to $4.44 billion in 2029 at a compound annual growth rate (CAGR) of 19.1%. The growth in the forecast period can be attributed to rising demand for discreet and user-friendly insulin delivery systems, increased focus on personalized diabetes management, expansion of reimbursement policies for advanced insulin devices, and growing awareness through digital health initiatives. Major trends in the forecast period include the integration of AI-powered glucose monitoring, enhanced smartphone app connectivity, miniaturization of patch devices, adoption of closed-loop systems, and wider use of wearable health technologies.

The rising prevalence of diabetes is expected to drive the growth of the tubeless insulin pump market in the coming years. Diabetes is a chronic condition characterized by high blood sugar due to the body's inability to produce or effectively use insulin. The increase in diabetes cases is largely linked to rising obesity rates, which are strongly associated with poor diet and physical inactivity. Tubeless insulin pumps help manage diabetes by delivering continuous, controlled doses of insulin without the need for multiple daily injections, effectively regulating blood sugar levels. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes. This number is projected to more than double, reaching 1.3 billion by 2050. Consequently, the growing prevalence of diabetes is fueling demand for tubeless insulin pumps.

Key players in the tubeless insulin pump market are focusing on developing advanced solutions, such as basal-only insulin pods, to provide simplified and cost-effective insulin delivery for individuals with type 2 diabetes who require only background insulin support. A basal-only insulin pod is a wearable pump that delivers a continuous background dose of insulin to help control blood sugar levels, primarily for those with type 2 diabetes. In April 2023, Insulet Corporation, a US-based medical device company, launched Omnipod GO, an insulin delivery device approved for use in adults with type 2 diabetes who would normally receive daily long-acting insulin injections. Omnipod GO is a wearable, independent device that delivers a constant rate of rapid-acting insulin for 72 hours. The tubeless and waterproof pod comes in seven pre-programmed daily rates ranging from 10 to 40 units and operates without the need for a mobile device.

In January 2023, Tandem Diabetes Care, a US-based insulin delivery and diabetes technology company, acquired AMF Medical SA for an undisclosed amount. This acquisition supports Tandem's sustainability initiatives by reducing battery waste through the Sigi pump's rechargeable design while expanding its portfolio of advanced insulin delivery solutions. AMF Medical SA, based in Switzerland, specializes in the manufacture of reusable patch (tubeless) insulin pumps.

Major players in the tubeless insulin pump market are F. Hoffmann-La Roche AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Becton Dickinson & Company, Fresenius Kabi AG, Terumo Corporation, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Ascensia Diabetes Care, MicroTech Medical, Menarini Diagnostics, Bigfoot Biomedical, Debiotech SA, Medtrum Technologies Inc., Diabeloop, SOOIL Development, and Beta Bionics.

North America was the largest region in the tubeless insulin pump market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tubeless insulin pump market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tubeless insulin pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tubeless insulin pump market consists of sales of infusion sets, insertion tools, adhesives pods, and handheld or smartphone-based controllers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tubeless Insulin Pump Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tubeless insulin pump market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tubeless insulin pump ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tubeless insulin pump market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Wearable Insulin Pump; Implantable Insulin Pump
  • 2) By Technology: Continuous Glucose Monitoring (CGM) Integrated Pumps; Standard Tubeless Pumps
  • 3) By End User: Hospitals; Pharmacies; E-Commerce; Other End Users
  • Subsegments:
  • 1) By Wearable Insulin Pump: Patch Pumps; Remote-Controlled Pumps; Bluetooth-Enabled Pumps; Disposable Pumps; Reusable Pumps
  • 2) By Implantable Insulin Pump: Programmable Implantable Pumps; Refillable Implantable Pumps; Microelectromechanical System (MEMS)-Based Pumps; Long-Acting Implantable Pumps; Biocompatible Coated Pumps
  • Companies Mentioned: F. Hoffmann-La Roche AG; Sanofi SA; Abbott Laboratories; Medtronic plc; Eli Lilly and Company; Becton Dickinson & Company; Fresenius Kabi AG; Terumo Corporation; Insulet Corporation; Tandem Diabetes Care Inc.; Ypsomed AG; Ascensia Diabetes Care; MicroTech Medical; Menarini Diagnostics; Bigfoot Biomedical; Debiotech SA; Medtrum Technologies Inc.; Diabeloop; SOOIL Development; Beta Bionics.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tubeless Insulin Pump Market Characteristics

3. Tubeless Insulin Pump Market Trends And Strategies

4. Tubeless Insulin Pump Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tubeless Insulin Pump Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tubeless Insulin Pump PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tubeless Insulin Pump Market Growth Rate Analysis
  • 5.4. Global Tubeless Insulin Pump Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tubeless Insulin Pump Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tubeless Insulin Pump Total Addressable Market (TAM)

6. Tubeless Insulin Pump Market Segmentation

  • 6.1. Global Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wearable Insulin Pump
  • Implantable Insulin Pump
  • 6.2. Global Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Continuous Glucose Monitoring (CGM) Integrated Pumps
  • Standard Tubeless Pumps
  • 6.3. Global Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Pharmacies
  • E-Commerce
  • Other End Users
  • 6.4. Global Tubeless Insulin Pump Market, Sub-Segmentation Of Wearable Insulin Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patch Pumps
  • Remote-Controlled Pumps
  • Bluetooth-Enabled Pumps
  • Disposable Pumps
  • Reusable Pumps
  • 6.5. Global Tubeless Insulin Pump Market, Sub-Segmentation Of Implantable Insulin Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Programmable Implantable Pumps
  • Refillable Implantable Pumps
  • Microelectromechanical System (MEMS)-Based Pumps
  • Long-Acting Implantable Pumps
  • Biocompatible Coated Pumps

7. Tubeless Insulin Pump Market Regional And Country Analysis

  • 7.1. Global Tubeless Insulin Pump Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tubeless Insulin Pump Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tubeless Insulin Pump Market

  • 8.1. Asia-Pacific Tubeless Insulin Pump Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tubeless Insulin Pump Market

  • 9.1. China Tubeless Insulin Pump Market Overview
  • 9.2. China Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tubeless Insulin Pump Market

  • 10.1. India Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tubeless Insulin Pump Market

  • 11.1. Japan Tubeless Insulin Pump Market Overview
  • 11.2. Japan Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tubeless Insulin Pump Market

  • 12.1. Australia Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tubeless Insulin Pump Market

  • 13.1. Indonesia Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tubeless Insulin Pump Market

  • 14.1. South Korea Tubeless Insulin Pump Market Overview
  • 14.2. South Korea Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tubeless Insulin Pump Market

  • 15.1. Western Europe Tubeless Insulin Pump Market Overview
  • 15.2. Western Europe Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tubeless Insulin Pump Market

  • 16.1. UK Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tubeless Insulin Pump Market

  • 17.1. Germany Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tubeless Insulin Pump Market

  • 18.1. France Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tubeless Insulin Pump Market

  • 19.1. Italy Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tubeless Insulin Pump Market

  • 20.1. Spain Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tubeless Insulin Pump Market

  • 21.1. Eastern Europe Tubeless Insulin Pump Market Overview
  • 21.2. Eastern Europe Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tubeless Insulin Pump Market

  • 22.1. Russia Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tubeless Insulin Pump Market

  • 23.1. North America Tubeless Insulin Pump Market Overview
  • 23.2. North America Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tubeless Insulin Pump Market

  • 24.1. USA Tubeless Insulin Pump Market Overview
  • 24.2. USA Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tubeless Insulin Pump Market

  • 25.1. Canada Tubeless Insulin Pump Market Overview
  • 25.2. Canada Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tubeless Insulin Pump Market

  • 26.1. South America Tubeless Insulin Pump Market Overview
  • 26.2. South America Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tubeless Insulin Pump Market

  • 27.1. Brazil Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tubeless Insulin Pump Market

  • 28.1. Middle East Tubeless Insulin Pump Market Overview
  • 28.2. Middle East Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tubeless Insulin Pump Market

  • 29.1. Africa Tubeless Insulin Pump Market Overview
  • 29.2. Africa Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tubeless Insulin Pump Market Competitive Landscape And Company Profiles

  • 30.1. Tubeless Insulin Pump Market Competitive Landscape
  • 30.2. Tubeless Insulin Pump Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Tubeless Insulin Pump Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson & Company
  • 31.2. Fresenius Kabi AG
  • 31.3. Terumo Corporation
  • 31.4. Insulet Corporation
  • 31.5. Tandem Diabetes Care Inc.
  • 31.6. Ypsomed AG
  • 31.7. Ascensia Diabetes Care
  • 31.8. MicroTech Medical
  • 31.9. Menarini Diagnostics
  • 31.10. Bigfoot Biomedical
  • 31.11. Debiotech SA
  • 31.12. Medtrum Technologies Inc.
  • 31.13. Diabeloop
  • 31.14. SOOIL Development
  • 31.15. Beta Bionics

32. Global Tubeless Insulin Pump Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tubeless Insulin Pump Market

34. Recent Developments In The Tubeless Insulin Pump Market

35. Tubeless Insulin Pump Market High Potential Countries, Segments and Strategies

  • 35.1 Tubeless Insulin Pump Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tubeless Insulin Pump Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tubeless Insulin Pump Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer